ACM
EXAS

Aubrey Capital Management’s Exact Sciences EXAS Stock Holding History

Aubrey Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-51,750
Closed -$3M – 56
2020
Q1 		$3M Sell
51,750
-1,000
-2% -$81.2K 1.86% 25
2019
Q4 		$4.88M Hold
52,750
– – 2.76% 9
2019
Q3 		$4.77M Buy
52,750
+2,000
+4% +$228K 2.92% 13
2019
Q2 		$5.99M Hold
50,750
– – 2.86% 12
2019
Q1 		$4.4M Buy
50,750
+10,250
+25% +$872K 2.12% 18
2018
Q4 		$2.56M Buy
40,500
+25,500
+170% +$1.75M 1.78% 21
2018
Q3 		$1.18M Buy
+15,000
New +$978K 0.58% 32

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Aubrey Capital Management's EXAS Position: Q2 2020 in Review

Aubrey Capital Management sold out of Exact Sciences (EXAS) in Q2 2020, closing a stake of 51,750 shares — an estimated $3M sold.

Aubrey Capital Management first reported a position in EXAS in Q3 2018 and held it in 7 quarters. The position peaked at $5.99M in Q2 2019. 512 funds tracked by Wall St. Rank hold EXAS as of Q2 2020.

  • Aubrey Capital Management reported no remaining Exact Sciences position as of Q2 2020 after selling out during the quarter.
  • Aubrey Capital Management sold 51,750 Exact Sciences shares in Q2 2020, an estimated $3M.
  • Aubrey Capital Management first reported a position in Exact Sciences in Q3 2018 and held it in 7 quarters.
  • Aubrey Capital Management's Exact Sciences position peaked at $5.99M in Q2 2019.
  • 512 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2020.

Based on Aubrey Capital Management's 13F filing for Q2 2020, filed 10 Aug 2020.